Financial insights of ENTX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-09-30	2024-12-31	2024-09-30
Revenues	0	0	33*	42
Cost of revenue	0	0	37*	42
Gross profit	0	0	-4*	0
Research and development expense	2,251	1,643	655*	1,477
General and administrative expense	1,288	1,613	1,128*	1,544
Net expenses related to opko collaboration agreement	3,539	3,256	1,782*	3,021
Operating loss	-3,539	-3,256	-1,786*	-3,021
Financial (income) expenses, net	34	56	-2*	-
Income (loss) from continuing operations before income taxes, noncontrolling interest	-	-	-1,788*	-3,021
Income tax expense (benefit)	-	-	4*	-
Net loss	-3,505	-3,200	-1,792	-3,021

Basic EPS	0.07	0.07	-0.047	0.08
Diluted EPS	0.07	0.07	-0.047	0.08
Basic Average Shares	47,756,409	47,089,814	38,215,765	37,644,612
Diluted Average Shares	47,756,409	47,089,814	38,215,765	37,644,612

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.